Research Analysts’ Updated EPS Estimates for August 21st (AADI, AMH, ANF, AS, ASPN, ATRA, BBAI, BBWI, BCSF, BTBT)

Research Analysts’ updated eps estimates for Wednesday, August 21st:

Aadi Bioscience (NASDAQ:AADI) had its neutral rating reissued by analysts at HC Wainwright.

American Homes 4 Rent (NYSE:AMH) had its outperform rating reaffirmed by analysts at Scotiabank. The firm currently has a $42.00 target price on the stock.

Abercrombie & Fitch (NYSE:ANF) had its outperform rating reissued by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $208.00 price target on the stock.

Amer Sports (NYSE:AS) had its outperform rating reissued by analysts at Evercore ISI. The firm currently has a $21.00 target price on the stock.

Aspen Aerogels (NYSE:ASPN) had its buy rating reiterated by analysts at Roth Mkm. The firm currently has a $36.00 target price on the stock.

Atara Biotherapeutics (NASDAQ:ATRA) had its neutral rating reaffirmed by analysts at HC Wainwright.

BigBear.ai (NYSE:BBAI) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $3.50 target price on the stock.

Bath & Body Works (NYSE:BBWI) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $53.00 price target on the stock.

Bain Capital Specialty Finance (NYSE:BCSF) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. The firm currently has a $17.00 target price on the stock.

Bit Digital (NASDAQ:BTBT) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $6.00 target price on the stock.

CollPlant Biotechnologies (NASDAQ:CLGN) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $11.00 price target on the stock.

Climb Global Solutions (NASDAQ:CLMB) had its outperform rating reissued by analysts at Barrington Research. The firm currently has a $90.00 target price on the stock.

Coty (NYSE:COTY) had its outperform rating reaffirmed by analysts at Evercore ISI. Evercore ISI currently has a $15.00 target price on the stock.

CEMEX (NYSE:CX) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. The firm currently has a $8.00 price target on the stock.

Data I/O (NASDAQ:DAIO) had its buy rating reissued by analysts at Westpark Capital. The firm currently has a $4.00 target price on the stock.

Diversified Healthcare Trust (NASDAQ:DHC) had its market perform rating reissued by analysts at JMP Securities.

Ecolab (NYSE:ECL) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $260.00 target price on the stock.

Electra Battery Materials (NASDAQ:ELBM) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $1.40 target price on the stock.

Eos Energy Enterprises (NASDAQ:EOSE) had its buy rating reiterated by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $6.00 target price on the stock.

Five9 (NASDAQ:FIVN) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $48.00 price target on the stock.

Five9 (NASDAQ:FIVN) had its overweight rating reissued by analysts at Piper Sandler. They currently have a $47.00 price target on the stock.

Foot Locker (NYSE:FL) had its market perform rating reiterated by analysts at Telsey Advisory Group. They currently have a $27.00 target price on the stock.

HIVE Digital Technologies (NASDAQ:HIVE) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $6.00 price target on the stock.

Hut 8 (NASDAQ:HUT) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $22.00 target price on the stock.

Iteris (NASDAQ:ITI) had its neutral rating reissued by analysts at B. Riley. The firm currently has a $7.20 price target on the stock, down from their previous price target of $8.00.

Itron (NASDAQ:ITRI) had its buy rating reiterated by analysts at Roth Mkm. The firm currently has a $125.00 price target on the stock.

Keysight Technologies (NYSE:KEYS) had its overweight rating reaffirmed by analysts at Wells Fargo & Company. The firm currently has a $180.00 target price on the stock.

Kohl’s (NYSE:KSS) had its market perform rating reaffirmed by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $23.00 target price on the stock.

Lowe’s Companies (NYSE:LOW) had its neutral rating reiterated by analysts at Wedbush. They currently have a $250.00 target price on the stock.

LAVA Therapeutics (NASDAQ:LVTX) had its market outperform rating reissued by analysts at JMP Securities. The firm currently has a $6.00 price target on the stock.

Macy’s (NYSE:M) had its market perform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $21.00 target price on the stock.

Medtronic (NYSE:MDT) had its sector perform rating reissued by analysts at Royal Bank of Canada. They currently have a $92.00 price target on the stock.

Magnite (NASDAQ:MGNI) had its buy rating reaffirmed by analysts at Craig Hallum. Craig Hallum currently has a $20.00 price target on the stock.

MacroGenics (NASDAQ:MGNX) had its neutral rating reissued by analysts at HC Wainwright. The firm currently has a $4.00 target price on the stock.

Mawson Infrastructure Group (NASDAQ:MIGI) had its neutral rating reissued by analysts at HC Wainwright.

Oncolytics Biotech (NASDAQ:ONCY) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $5.00 price target on the stock.

Perdoceo Education (NASDAQ:PRDO) had its outperform rating reissued by analysts at Barrington Research. Barrington Research currently has a $30.00 target price on the stock.

Prudential Financial (NYSE:PRU) had its market perform rating reiterated by analysts at Keefe, Bruyette & Woods. They currently have a $121.00 target price on the stock.

PTC Therapeutics (NASDAQ:PTCT) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $64.00 price target on the stock.

Arcadia Biosciences (NASDAQ:RKDA) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $6.00 target price on the stock.

Seacoast Banking Co. of Florida (NASDAQ:SBCF) had its outperform rating reaffirmed by analysts at Keefe, Bruyette & Woods. They currently have a $31.00 price target on the stock.

Summit Therapeutics (NASDAQ:SMMT) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $16.00 target price on the stock.

Emeren Group (NYSE:SOL) had its buy rating reissued by analysts at HC Wainwright. They currently have a $7.00 target price on the stock.

Emeren Group (NYSE:SOL) had its buy rating reissued by analysts at Roth Mkm. They currently have a $3.00 target price on the stock.

Target (NYSE:TGT) had its overweight rating reiterated by analysts at Morgan Stanley. They currently have a $180.00 price target on the stock.

TJX Companies (NYSE:TJX) had its outperform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $128.00 target price on the stock.

Toll Brothers (NYSE:TOL) had its neutral rating reissued by analysts at Wedbush. The firm currently has a $120.00 price target on the stock.

Toll Brothers (NYSE:TOL) had its outperform rating reiterated by analysts at Keefe, Bruyette & Woods. The firm currently has a $142.00 price target on the stock.

Take-Two Interactive Software (NASDAQ:TTWO) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $190.00 price target on the stock.

Take-Two Interactive Software (NASDAQ:TTWO) had its buy rating reiterated by analysts at Bank of America Co.. The firm currently has a $185.00 price target on the stock.

Texas Instruments (NASDAQ:TXN) had its neutral rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $210.00 target price on the stock.

Utz Brands (NYSE:UTZ) had its overweight rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $22.00 target price on the stock.

Zeta Global (NASDAQ:ZETA) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $28.00 target price on the stock.